Study to Assess the Concentration of Avibactam and Ceftazidime in Epithelial Lining Fluid and Plasma
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is an open-label study divided in 2 parts and 3 cohorts to determine the concentration
of Avibactam and Ceftazidime in the lining of the lungs and the blood.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca Pfizer
Treatments:
Avibactam Avibactam, ceftazidime drug combination Ceftazidime